KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Capital Leases: 2017-2025

Historic Capital Leases for Astrana Health (ASTH) over the last 9 years, with Q1 2025 value amounting to $543000.0.

  • Astrana Health's Capital Leases fell 4650.25% to $543000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $543000.0, marking a year-over-year decrease of 4650.25%. This contributed to the annual value of $607000.0 for FY2024, which is 4123.91% down from last year.
  • According to the latest figures from Q1 2025, Astrana Health's Capital Leases is $543000.0, which was down 4650.25% from $607000.0 recorded in Q4 2024.
  • Astrana Health's Capital Leases' 5-year high stood at $1.3 million during Q4 2022, with a 5-year trough of $221000.0 in Q3 2021.
  • Its 5-year average for Capital Leases is $845647.1, with a median of $973000.0 in 2021.
  • As far as peak fluctuations go, Astrana Health's Capital Leases surged by 32310.47% in 2022, and later tumbled by 4650.25% in 2025.
  • Over the past 5 years, Astrana Health's Capital Leases (Quarter) stood at $973000.0 in 2021, then soared by 31.04% to $1.3 million in 2022, then decreased by 18.98% to $1.0 million in 2023, then plummeted by 41.24% to $607000.0 in 2024, then decreased by 10.54% to $543000.0 in 2025.
  • Its last three reported values are $543000.0 in Q1 2025, $607000.0 for Q4 2024, and $743000.0 during Q3 2024.